Quantcast

Latest Sexual arousal Stories

2014-07-01 12:28:14

For Men Confused in the Bedroom, Dr. Emily Morse Has 5 Tips for Hitting the Big O LOS ANGELES, July 1, 2014 /PRNewswire/ -- Promescent, maker of the first FDA-compliant treatment for premature ejaculation (PE), has found that over 30% of men are not sure how to please their partner in the bedroom. The company issued surveys to men and women, and the findings are crystal clear: men need some help. According to the survey, 40% of women achieve orgasm less than half of the times they have sex,...

2014-06-25 23:08:46

Boston Medical Group offers $395 Diagnostic Tests at No Cost June 30 – July 11th Los Angeles, California (PRWEB) June 25, 2014 With military veterans at higher risk of experiencing sexual dysfunction than the general male population and in light of the recent scandal facing the U.S. Department of Veterans Affairs about the delayed medical care of our veterans, Boston Medical Group (BMG), the nation’s largest private men’s sexual health clinics, will offer free diagnostic tests from...

2014-06-10 23:09:43

For men with erectile problems, taking one of the four medications available can produce an erection 70% of the time. Boston, MA (PRWEB) June 10, 2014 For the estimated half of men between the ages of 40 and 70 who have trouble getting or sustaining an erection, taking a medication can often remedy the problem. With four erectile dysfunction drugs on the market, men have options. But their choices are often limited by cost and health insurance rules, reports the June 2014 Harvard...

2014-06-06 12:24:21

Dr. Michael Zahalsky Presents Results During American Urological Association Medical Conference CORAL SPRINGS, Fla., June 6, 2014 /PRNewswire-iReach/ -- Dr. Michael Zahalsky, a prominent South Florida Urologist, was chosen to give a podium presentation at the 2014 Annual Meeting of the American Urological Association, May 16-21 in Orlando to discuss the results of his research on the use of stem cells to treat erectile dysfunction. Over a six-month period, Dr. Zahalsky studied the...

2014-06-04 20:22:03

Persistent gender inequity at FDA has led to 26 approved drugs for men, and ZERO for women WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- Highlighting a persistent gender inequity at the Food and Drug Administration regarding the approval of treatments for the most common forms of sexual dysfunction, a diverse group of women's health and research organizations today launched Even the Score, a new advocacy campaign created to serve as a voice for American women who believe that it's time...

2014-05-28 08:30:26

Women treated with Tefina(TM) 0.6 mg reported a statistically significant increase in orgasms versus placebo TORONTO, May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina(TM), a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD). FOD, also known as anorgasmia, is characterized by a delay, absence or reduced intensity of...

2014-05-20 08:34:24

Data show many women are not aware of hypoactive sexual desire disorder and often blame themselves for symptoms of low desire RED BANK, N.J., May 20, 2014 /PRNewswire/ -- Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these women (61%) felt distressed by it, according to a new national survey. Low sexual desire that is accompanied by distress and strains a woman's relationship with her...

2014-05-06 16:33:46

CRANBURY, N.J., May 6, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunction were presented at the American Psychiatric Association (APA) 2014 Annual Meeting in New York, NY on Tuesday, May 6, 2014 at 2:30 PM ET. APA is the world's largest psychiatric organization. Bremelanotide is a first-in-class,...

2014-04-29 08:35:16

CRANBURY, N.J., April 29, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunction were presented at the American College of Obstetricians and Gynecologists (ACOG) 2014 Annual Clinical Meeting in Chicago, IL on Monday, April 28, 2014 at 3:45 PM local time. ACOG is the nation's leading group of...

2014-04-23 09:32:33

Findings could help scientists study pain-inhibited sexual desire in humans "Not tonight, dear, I have a headache." Generally speaking, that line is attributed to the wife in a couple, implying that women's sexual desire is more affected by pain than men's. Now, researchers from McGill University and Concordia University in Montreal have investigated, possibly for the first time in any species, the direct impact of pain on sexual behavior in mice. Their study, published in the April 23...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related